Results 81 to 90 of about 64,981 (166)

Wnt Signaling Downregulation Mediates T Cell Apoptosis Following OKT3-Induced T Cell Activation in Preclinical Models. [PDF]

FASEB J
Choi M, Park D, Lee DH, Choi CH, Jo M, Jeong SY, Lim SY, Park D, Moon KS.   +8 more
europepmc   +1 more source

Targeted Therapy in Hepatobiliary Pancreatic Cancer (HPC): Advantages and Advancements of Antibody Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. [PDF]

Int J Mol Sci
Deb Nath T, Mukherjee A, Chauhan SC, Bandyopadhyay D.   +3 more
europepmc   +1 more source

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity. [PDF]

iScience
Kratochvil S, Kullmann M, Gruell H, Sayettat S, Tsai CH, Vukovic N, Janaitis C, Lindemann C, Praßl S, Stumpf R, Knüfer J, Tolksdorf F, Şahin U, Nelke J, Malz A, Schommers P, Bhebhe S, Mkhize N, Moore P, Seaman MS, Klein F, Le Douce V.   +21 more
europepmc   +1 more source

Tau and β-Amyloid Relevant Pathology as a Central Therapeutic Target in Alzheimer's Disease. [PDF]

Biomolecules
Strużyńska L, Adamiak K, Sidoryk-Węgrzynowicz M.   +2 more
europepmc   +1 more source

Obinutuzumab after anti-rituximab antibody-associated treatment failure in membranous nephropathy: a case report. [PDF]

Front Immunol
Guo J, Zhong A, Wu D, Liu Y, Chen Y, Xu Y, Xu R, Wan Q.   +7 more
europepmc   +1 more source

In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences. [PDF]

Alzheimers Res Ther
Mueller A, Jovalekic A, Chapleau M, Seidel J, Ritter M, Bickel EM, Kiessling N, MacSweeney E, Stephens AW, Koglin N.   +9 more
europepmc   +1 more source

Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safety. [PDF]

MAbs
Siegel M, Zhu E, Rios D, Kang BH, McNally J, Kennedy M, Hew K, Patel P, Ballew O, Giles DH, Lewis EMA, LaFountaine J, Oh J, Friedman JR, Rose MJ, Shaheen H, Spencer AG.   +16 more
europepmc   +1 more source

Role of IL-5 in eosinophil-associated diseases and prospects for multi-target therapy. [PDF]

Front Immunol
Ou W, Wang Y, Hou C, Hou S, Zhou Y, Wang J, Wang Q.   +6 more
europepmc   +1 more source

Comparison of chimeric mouse-human and humanized anti-CD25 monoclonal antibodies for steroid-refractory acute graft-versus-host disease. [PDF]

Front Immunol
Zheng X, Zhou Y, Zheng Y, Lu N, Cao Y, Zhai W, Wei J, Yang D, Zhang R, Pang A, Feng S, Han M, Jiang E, Chen X.   +13 more
europepmc   +1 more source